Veterinary Medicines

Zeronil Combo 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs.

Not authorised
  • (S)-Methoprene
  • Fipronil
Download as PDF

Product identification

Medicine name:
Zeronil Combo 402 mg/361.8 mg Spot-on Solution for Extra Large Dogs.
Fleatix Comp vet 402 mg/361,8 mg Spot-on, lösning
Active substance:
  • (S)-Methoprene
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • (S)-Methoprene
    361.80
    milligram(s)
    /
    1.00
    Pipette
  • Fipronil
    402.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX65
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Sweden
Package description:
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 160 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 150 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 90 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 60 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 30 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 24 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 21 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 20 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 18 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 15 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 12 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 10 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 9 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 8 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 6 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 4 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 3 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 2 pipettes in individual foil sachets.
  • A white pipette composed of a heat-formed shell of polypropylene/cyclic olefin copolymer/polypropylene layer and polyethylene/ethylene vinyl alcohol/polyethylene layer. Box with 1 pipette in an individual foil sachet.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 56154
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0386/005

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
Swedish (PDF)
Published on: 2/05/2022
Download

Combined File of all Documents

English (PDF)
Published on: 13/04/2025
Download